Literature DB >> 10603032

Ultrastructural evidence of early non-fibrillar Abeta42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type.

R Natté1, H Yamaguchi, M L Maat-Schieman, F A Prins, P Neeskens, R A Roos, S G van Duinen.   

Abstract

The C-terminal profile and ultrastructure of small and presumably early capillary amyloid beta protein (Abeta) deposits were investigated in four patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type. The C terminus of the 40 (Abeta40) or the 42 (Abeta42) amino acid form of Abeta was gold labeled in serial, ultrathin sections on glass slides for reflection contrast microscopy and on grids for electron microscopy. In all studied subjects, reflection contrast microscopy revealed capillaries with focal Abeta42 immunolabeling in the absence of Abeta40 labeling. In the adjacent electron microscopic section, Abeta42 labeling was confined to the capillary basement membrane. The majority of Abeta42(+)40(-) deposits showed no amyloid fibrils. Abeta42(+)40(-) deposits were sometimes observed in an unremarkable basement membrane but usually showed increased electron density and reticular structures. A small subset of Abeta42(+)40(-) deposits with basement membrane changes showed few amyloid fibrils. Abeta42(+)40(+) capillary deposits always showed definite fibrils and were larger than Abeta42(+)40(-) capillary deposits. The present findings suggest that in capillaries the accumulation and subsequent polymerization of Abeta42, possibly in conjunction with basement membrane changes, precedes the definite fibril formation with Abeta40.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603032     DOI: 10.1007/s004010051121

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  5 in total

Review 1.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

Review 2.  Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy.

Authors:  Vitaly Vasilevko; Giselle F Passos; Daniel Quiring; Elizabeth Head; Richard C Kim; Mark Fisher; David H Cribbs
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 3.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

4.  β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.

Authors:  Ellis S van Etten; Marcel M Verbeek; Jeroen van der Grond; Ronald Zielman; Sanneke van Rooden; Erik W van Zwet; Anna M van Opstal; Joost Haan; Steven M Greenberg; Mark A van Buchem; Marieke J H Wermer; Gisela M Terwindt
Journal:  Neurology       Date:  2016-11-30       Impact factor: 9.910

5.  Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.

Authors:  Grace M Lloyd; Jorge A Trejo-Lopez; Yuxing Xia; Karen N McFarland; Sarah J Lincoln; Nilüfer Ertekin-Taner; Benoit I Giasson; Anthony T Yachnis; Stefan Prokop
Journal:  Acta Neuropathol Commun       Date:  2020-03-12       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.